| Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
|---|---|---|---|---|---|---|---|
| Primex-40 | |||||||
| Wellness Forever Medicare Limited |
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Non-Current Assets |
|
|
|
Property, Plant And Equipment |
43.28 |
56.88 |
|
Right-Of-Use Assets |
212.76 |
225.91 |
|
Capital Work In Progress |
0.11 |
0.54 |
|
Intangible Assets |
4.33 |
7.12 |
|
Intangible Assets Under Development |
0.16 |
0.09 |
|
Financial Assets - Loans |
0.42 |
0.05 |
|
Financial Assets - Other Financial Assets |
65.55 |
47.17 |
|
Income Tax Assets (Net) |
5.78 |
3.04 |
|
Deferred Tax Assets (Net) |
54.41 |
45.34 |
|
Other Non-Current Assets |
3.31 |
3.12 |
|
Current Assets |
|
|
|
Inventories |
217.52 |
225.00 |
|
Financial Assets - Trade Receivables |
67.13 |
47.28 |
|
Financial Assets - Cash And Cash Equivalents |
32.43 |
22.73 |
|
Financial Assets - Bank Balances Other Than Above |
28.36 |
18.10 |
|
Financial Assets - Loans |
0.19 |
0.95 |
|
Financial Assets - Other Financial Assets |
21.23 |
16.73 |
|
Other Current Assets |
15.35 |
11.57 |
|
Total Assets |
772.32 |
731.59 |
|
Equity |
|
|
|
Equity Share Capital |
11.16 |
11.16 |
|
Instruments Entirely Equity In Nature |
25.00 |
- |
|
Other Equity |
191.13 |
205.41 |
|
Non-Current Liabilities |
|
|
|
Financial Liabilities - Borrowings |
19.56 |
13.49 |
|
Financial Liabilities - Lease Liabilities |
166.79 |
163.79 |
|
Provisions |
11.95 |
7.80 |
|
Current Liabilities |
|
|
|
Financial Liabilities - Borrowings |
109.15 |
109.08 |
|
Financial Liabilities - Lease Liabilities |
69.71 |
77.84 |
|
Trade Payables - Micro And Small Enterprises |
12.24 |
9.33 |
|
Trade Payables - Other Than Micro And Small
Enterprises |
138.55 |
104.69 |
|
Other Financial Liabilities |
5.86 |
17.51 |
|
Other Current Liabilities |
8.01 |
8.99 |
|
Provisions |
3.22 |
2.51 |
|
Total Equity And Liabilities |
772.32 |
731.59 |
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Income |
|
|
|
Revenue from operations |
1,663.38 |
1,562.05 |
|
Other income |
9.71 |
9.18 |
|
Total income |
1,673.08 |
1,571.22 |
|
Expenses |
|
|
|
Purchases of stock-in-trade |
1,194.04 |
1,144.69 |
|
Changes in inventories of stock-in-trade |
7.48 |
-15.83 |
|
Employee benefits expense |
193.17 |
184.88 |
|
Finance costs |
38.34 |
37.54 |
|
Depreciation and amortisation expenses |
115.88 |
119.56 |
|
Other expenses |
147.41 |
157.21 |
|
Total expenses |
1,696.30 |
1,628.05 |
|
Loss before tax |
-23.22 |
-56.82 |
|
Deferred tax |
-8.50 |
-9.41 |
|
Loss for the year |
-14.72 |
-47.42 |
|
Other comprehensive income |
|
|
|
Remeasurement of net defined benefit plan |
-2.29 |
-1.34 |
|
Income tax relative to above |
0.57 |
0.34 |
|
Total comprehensive loss for the year |
-16.44 |
-48.41 |
|
Earnings per equity share |
|
|
|
Basic & Diluted |
-2.64 |
-8.50 |
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Cash flows from operating activities |
|
|
|
Loss before tax |
-23.22 |
-56.82 |
|
Adjustments for: |
|
|
|
Finance costs |
38.34 |
37.54 |
|
Interest income |
-6.47 |
-6.11 |
|
Interest on Income Tax refund |
- |
-0.63 |
|
Loss on disposal of property, plant and equipment
(net) |
1.50 |
3.35 |
|
Depreciation and amortisation expenses |
115.88 |
119.56 |
|
Employee share-based payment expense |
2.12 |
3.29 |
|
Loss allowances |
0.62 |
6.13 |
|
Gain on termination of lease |
-1.10 |
-1.37 |
|
Net gain on redemption of mutual fund |
-0.06 |
-0.12 |
|
Operating cash flows before movement in working
capital |
127.60 |
104.82 |
|
(Increase)/decrease in operating assets |
|
|
|
Trade receivables |
-20.47 |
5.35 |
|
Inventories |
7.48 |
-15.83 |
|
Other financial assets |
2.22 |
-4.70 |
|
Other assets |
-4.26 |
3.72 |
|
Increase/(decrease) in operating liabilities |
|
|
|
Trade payables |
36.76 |
64.38 |
|
Provisions |
2.58 |
2.86 |
|
Other financial liabilities |
-11.82 |
-0.45 |
|
Other current liabilities |
-0.98 |
1.51 |
|
Changes in working capital |
11.50 |
56.83 |
|
Cash generated from operations |
139.11 |
161.65 |
|
Income taxes paid (net of refund) |
-2.74 |
4.85 |
|
Net cash generated from operating activities |
136.37 |
166.50 |
|
Cash flows from investing activities |
|
|
|
(Investment in)/proceeds from redemption of
deposit with banks (net) |
-35.62 |
-13.82 |
|
(Investment in)/proceeds from redemption of
mutual funds (net) |
0.06 |
8.13 |
|
Loan given to/(repaid by) employees (net) |
0.38 |
-0.22 |
|
Interest received |
1.55 |
1.46 |
|
Purchase of property, plant and equipment and
other intangible assets |
-9.51 |
-13.51 |
|
Proceeds on disposal of property, plant and
equipment |
0.43 |
0.92 |
|
Net cash used in investing activities |
-42.71 |
-17.05 |
|
Cash flows from financing activities |
|
|
|
Proceeds from issue of instruments entirely
equity in nature incl. securities premium |
25.00 |
- |
|
Proceeds from issue of equity shares including
securities premium |
0.16 |
0.72 |
|
Proceeds/(repayment) of long term borrowings |
-5.96 |
-17.20 |
|
Proceeds from liability towards failed sale and
lease back transaction |
7.39 |
- |
|
Repayment of liability towards failed sale and
lease back transaction |
-0.65 |
- |
|
Repayment of short term borrowings (net) |
5.89 |
-30.42 |
|
Principal repayment of lease liabilities |
-77.45 |
-80.18 |
|
Interest paid on lease liabilities |
-22.61 |
-21.33 |
|
Interest paid |
-14.88 |
-15.85 |
|
Interest paid on liability towards failed sale
and lease back transaction |
-0.84 |
- |
|
Net cash (used in)/generated by financing
activities |
-83.96 |
-164.25 |
|
Net increase/(decrease)
in cash and cash equivalents |
9.70 |
-14.79 |
|
Cash and cash equivalents at the beginning of the
year |
22.73 |
37.52 |
|
Cash and cash equivalents at the end of the year |
32.43 |
22.73 |
Summary
of Cash Flow Statement for the years 2026 and 2025:
Cash Flow
from Operating Activities: The company reported net cash
generated from operating activities of Rs. 136.37 crores in FY 2025-26,
compared to Rs. 166.50 crores in FY 2024-25, indicating a decline in operating
cash flow. Although the loss before tax reduced significantly from Rs. 56.82
crores to Rs. 23.22 crores, operating cash flows before working capital
movements improved from Rs. 104.82 crores to Rs. 127.60 crores. However,
changes in working capital contributed Rs. 11.50 crores during FY 2025-26,
compared to Rs. 56.83 crores in the previous year. Higher trade receivables and
other asset-related cash outflows partly offset the benefits from increased
trade payables. Overall, the company maintained positive operating cash flows,
reflecting its ability to generate cash from its core business operations.
Cash Flow
from Investing Activities: The company reported net cash used
in investing activities of Rs. 42.71 crores in FY 2025-26, compared to Rs.
17.05 crores in FY 2024-25, indicating higher investment-related cash outflows.
The major cash outflow was Rs. 35.62 crores towards net investment in bank
deposits, while Rs. 9.51 crores was spent on purchasing property, plant and
equipment and other intangible assets. The company also received interest
income of Rs. 1.55 crores and proceeds from the disposal of fixed assets
amounting to Rs. 0.43 crores. Overall, the increased investing outflow
indicates greater allocation of funds towards bank deposits and
business-related investments during the year.
Cash Flow
from Financing Activities: The company reported net cash used
in financing activities of Rs. 83.96 crores in FY 2025-26, compared to Rs.
164.25 crores in FY 2024-25, reflecting a substantial reduction in
financing-related cash outflows. During the year, the company raised Rs. 25.00
crores through the issue of instruments entirely equity in nature and received
Rs. 7.39 crores from a liability related to a failed sale and leaseback
transaction. It also recorded a net repayment of long-term borrowings of Rs.
5.96 crores. Significant cash outflows included principal repayment of lease
liabilities of Rs. 77.45 crores, interest paid on lease liabilities of Rs.
22.61 crores and other interest payments. Overall, the lower financing outflow
indicates an improvement in the company 's financing cash position, supported by
fresh capital raised and reduced repayment of borrowings.
Net
Increase/(Decrease) in Cash and Cash Equivalents: The
company recorded a net increase in cash and cash equivalents of Rs. 9.70 crores
in FY 2025-26, compared to a net decrease of Rs. 14.79 crores in FY 2024-25.
Consequently, cash and cash equivalents increased from Rs. 22.73 crores at the
beginning of the year to Rs. 32.43 crores at the end of FY 2025-26. The
positive cash balance reflects the company 's ability to generate sufficient
operating cash flows to meet its investing and financing requirements while
improving its overall cash position. Overall, the company demonstrated an
improvement in cash flow management during FY 2025-26, despite lower operating
cash generation and higher investing outflows.
Financial ratios of Wellness Forever Medicare Limited
|
Particulars |
31-03-2026 |
31-03-2025 |
|
Current Ratio |
1.11 |
1.04 |
|
Debt-Equity Ratio |
0.46 |
0.44 |
|
Debt Service Coverage Ratio |
0.87 |
0.56 |
|
Return on Equity |
-0.08 |
-0.22 |
|
Inventory Turnover Ratio |
5.46 |
5.30 |
|
Trade Receivables Turnover Ratio |
28.67 |
27.06 |
|
Trade Payables Turnover Ratio |
10.67 |
13.84 |
|
Net Capital Turnover Ratio |
45.75 |
129.00 |
|
Net Profit Margin |
-0.01 |
-0.04 |
|
Return on Capital Employed |
-0.03 |
-0.16 |
|
Return On Investment |
0.06 |
0.07 |
Summary of Financial Ratios for the year
2026 and 2025:
Current
Ratio: The current ratio increased from 1.04 in FY 2024-25 to
1.11 in FY 2025-26, indicating a slight improvement in the company 's short-term
liquidity position. However, the ratio remains below the generally preferred
benchmark of 2:1, suggesting that the company may have limited capacity to meet
its short-term obligations.
Debt-Equity
Ratio: The debt-equity ratio increased marginally from 0.44 in
FY 2024-25 to 0.46 in FY 2025-26, indicating a slight rise in the company 's
dependence on borrowed funds compared to shareholders ' equity. However, the
ratio remains relatively moderate, suggesting a reasonable balance between debt
and equity financing.
Debt
Service Coverage Ratio: The debt service coverage ratio improved
from 0.56 in FY 2024-25 to 0.87 in FY 2025-26, indicating an improvement in the
company 's ability to generate earnings to meet its debt repayment obligations.
However, the ratio remains below 1, suggesting that the company 's operating
earnings are still insufficient to comfortably cover its debt servicing
requirements.
Return on
Equity: The return on equity improved from -0.22 in FY 2024-25
to -0.08 in FY 2025-26, indicating a reduction in losses relative to
shareholders ' equity. Despite the improvement, the negative ratio reflects that
the company continues to generate negative returns for its shareholders.
Inventory
Turnover Ratio: The inventory turnover ratio increased
slightly from 5.30 in FY 2024-25 to 5.46 in FY 2025-26, indicating an
improvement in inventory management and the efficiency of stock movement. This
suggests that the company has become slightly more efficient in converting its
inventory into sales during the year.
Trade
Receivables Turnover Ratio: The trade receivables turnover ratio
increased from 27.06 in FY 2024-25 to 28.67 in FY 2025-26, indicating improved
efficiency in collecting payments from customers. This reflects better
receivables management and a faster collection cycle.
Trade
Payables Turnover Ratio: The trade payables turnover ratio declined
from 13.84 in FY 2024-25 to 10.67 in FY 2025-26, indicating that the company is
taking relatively longer to make payments to its suppliers. This may reflect
changes in payment practices or greater utilisation of supplier credit.
Net
Capital Turnover Ratio: The net capital turnover ratio declined
significantly from 129.00 in FY 2024-25 to 45.75 in FY 2025-26, indicating a
substantial reduction in the efficiency with which the company utilises its
working capital to generate revenue. This suggests comparatively lower working
capital utilisation efficiency during the year.
Net
Profit Margin: The net profit margin improved from -0.04
in FY 2024-25 to -0.01 in FY 2025-26, indicating a reduction in losses in
relation to revenue. Although the company has moved closer to profitability,
the negative margin indicates that it continues to incur net losses.
Return on
Capital Employed: The return on capital employed improved
from -0.16 in FY 2024-25 to -0.03 in FY 2025-26, indicating a significant
reduction in losses generated relative to the capital employed. However, the
negative ratio suggests that the company has not yet achieved positive returns
from its capital investments.
Return on
Investment: The return on investment declined slightly from 0.07 in
FY 2024-25 to 0.06 in FY 2025-26, indicating a marginal decrease in the returns
generated from investments. This suggests a slight reduction in investment
performance compared to the previous year.